KDA Group Inc
XTSX:KDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (5.8), the stock would be worth CA$0.2 (63% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.5 | CA$0.12 |
0%
|
| 3-Year Average | 5.8 | CA$0.2 |
+63%
|
| 5-Year Average | 2.9 | CA$0.1 |
-17%
|
| Industry Average | 1.4 | CA$0.05 |
-60%
|
| Country Average | 1.7 | CA$0.06 |
-53%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
KDA Group Inc
XTSX:KDA
|
28.2m CAD | 3.5 | -4.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 0.8 | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 0.8 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 0 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 0.8 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 1 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 1.5 | 24.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 1.8 | 21.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 15.7 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 1.2 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1 |
| Median | 1.7 |
| 70th Percentile | 3.7 |
| Max | 95 179.6 |
Other Multiples
KDA Group Inc
Glance View
KDA Group, Inc. engages in the provision of solutions and services to pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates in three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. The Pharmacy Services segment provides pharmacy staff and placement and consulting services and training. The Pharmaceutical Solutions provides medical communication, technology solutions and health communication. The Technology segment offers software applications, including Virtual Clinics, Virtual Pharmacy, eCommerce for orders of medical cannabis products and Counselling and training Services on medical cannabis products for doctors, pharmacists and patients. Its subsidiaries include Alliance Pharma Operations inc., Elitis Pharma inc., Logistik Pharma inc., CanNorth Medic inc., Groupe Technologique KDA inc., CanNorth Medic International inc. and Pharmapar inc.
